Mednet Logo

How would you approach management and monitoring of AL amyloidosis with isolated renal involvement?

AL amyloid biopsy proven on renal biopsy. Normal SPEP and FLC, bone marrow biopsy with 10-15% plasma cells.
2 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Washington, Fred Hutchinson Cancer Research Center
Answered on

This is tough for sure, and my first question would be to ask how the renal biopsy was determined to be AL amyloidosis. Sometimes typing isn't required if the pattern is overwhelmingly lambda-restricted or kappa-restricted by immunofluorescence... but in this case, mass spectrometry typing may be wo...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Chicago
Answered on

Assuming the diagnosis is correct, my preference is to approach management with Dara-CyBorD induction as in ANDROMEDA followed by Dara maintenance. Upfront ASCT is reasonable in cases of renal-only amyloidosis, though with 10-15% disease, I would favor induction anyhow.

For disease monitoring, 24-hou...

Join for free or sign in to see the full answer